Suven Life Sciences
Business Services · India · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8-2-334 Sde Serene Chambers 6th Floor Ro...Phone Number
+91 4023541142Website
www.suven.comRevenue
<$5 MillionIndustry
About Suven Life Sciences
Suven, Inc. a Delaware company, a wholly owned subsidiary of Suven Life Sciences Limited, India, is a clinical-stage biopharmaceutical company focused on acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. Suven Life Sciences' discovery research programs are focused on discovering and developing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets, having world wide patents. Suven has 3 clinical stage compounds, a Phase 2 initiated candidate SUVN-502, Phase 1 completed candidate SUVN-G3031 and Phase 1 initiated candidate SUVN-D-4010 for Alzheimer's disease and Schizophrenia. In addition, the Company has Ten (10) internally-discovered therapeutic drug candidates currently in pre-clinical stage of development targeting conditions such as ADHD, dementia, depression, Huntington's disease, Parkinson's disease and pain.Explore more
SIC Code 87,873NAICS Code 54,541Show moreSuven Life Sciences Org Chart
Suven Life Sciences Tech Stack
A closer look at the technologies used by Suven Life Sciences
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Suven Life Sciences
Sign Up For FreeTo access detailed company insights
Suven, Inc. a Delaware company, a wholly owned subsidiary of Suven Life Sciences Limited, India, is a clinical-stage biopharmaceutical company focused on acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. Suven Life Sciences' discovery research programs are focused on discovering a... Read More